US Patent Issued to Helen Liu, KOUSAI Bio on Sept. 23 for "Epstein-Barr virus (EBV) antigen composites and dendritic cell (DC)-based vaccine, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,912, issued on Sept. 23, was assigned to Helen Liu (Shanghai) and KOUSAI Bio Co. Ltd (Shanghai).

"Epstein-Barr virus (EBV) antigen composites and dendritic cell (DC)-based vaccine, and use thereof" was invented by Helen Liu (Shanghai) and Ze Yin (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Epstein-Barr virus (EBV) antigen composites and a dendritic cell (DC)-based vaccine, and a use thereof in preparation of a drug for controlling an EBV-associated infectious disease are provided. Patient-derived DCs are stimulated in vitro, loaded with lysates of various types of EBV-infected cells with strong immunogenicity for EBV-associated infectio...